admin

Dive Brief: Findings from a September consumer sentiment survey initiated by investment firm Needham & Company of 257 older people across the U.S. suggest increasing willingness to have elective procedures, even as the pandemic continues. The time between when consumers were surveyed and when they’d be comfortable having a procedure is shrinking, from an average
0 Comments
Dive Brief: FDA on Tuesday announced the creation of a digital health center within the Center for Devices and Radiological Health where it will coordinate policy and regulatory approaches tailored for the technologies. Bakul Patel, who has led the agency’s digital health regulatory and scientific efforts for the past decade, was named the center’s first director.
0 Comments
Dive Brief: The U.S. Patent and Trademark Office’s Patent Trial and Appeal Board has decided to move forward in reviewing claims made by sacral neuromodulation specialist Axonics against Medtronic. Irvine, California-based Axonics gained an FDA approval one year ago to become Medtronic’s first challenger in the market for neurostimulators to treat fecal incontinence and has
0 Comments
CDC recommends that people wear masks in public settings and when around people who don’t live in your household, especially when other social distancing measures are difficult to maintain. Masks may help prevent people who have COVID-19 from spreading the virus to others. Masks are most likely to reduce the spread of COVID-19 when they are
0 Comments
Print this page ROCKVILLE, MD, Sept. 22, 2020 (GLOBE NEWSWIRE) –  MacroGenics, Inc. (NASDAQ: MGNX), a clinical-stage biopharmaceutical company focused on discovering and developing innovative monoclonal antibody-based therapeutics for the treatment of cancer, today announced the publication of a manuscript in Blood, a journal of the American Society of Hematology, which highlights interim results of an ongoing Phase
0 Comments
Print this page NEW BRUNSWICK, N.J., September 23, 2020 – Johnson & Johnson (NYSE: JNJ) (the Company) today announced the launch of its large-scale, pivotal, multi-country Phase 3 trial (ENSEMBLE) for its COVID-19 vaccine candidate, JNJ-78436735, being developed by its Janssen Pharmaceutical Companies. The initiation of the ENSEMBLE trial follows positive interim results from the Company’s Phase 1/2a
0 Comments
Print this page TOKYO — September 23, 2020 FUJIFILM Toyama Chemical Co., Ltd. (President: Junji Okada; hereinafter “FUJIFILM Toyama Chemical”) has announced today that primary endpoint has been met in phase III clinical trial of “Avigan Tablet” (generic name: favipiravir, “Avigan”) conducted in Japan for patients with novel coronavirus infections (hereinafter “COVID-19”). The efficacy primary
0 Comments
Washington: US President Donald Trump on Wednesday (local time) said that his administration may or may not approve a proposal from the Food and Drug Administration (FDA) that would tighten guidelines for approving a novel coronavirus disease (Covid-19) vaccine. On Tuesday, the Washington Post reported that the FDA would consider stricter guidelines to approve a
0 Comments
PUNE: The Food and Drug Administration (FDA) on Wednesday, while confirming the arrival of 20,000 vials of remdesivir in Pune division, said patients’ relatives should not approach retail medical stores or wholesale distributors to purchase the drug. Officials said the drug is now being supplied directly to all hospitals treating Covid-19. They asked families to
0 Comments
Adrianna Rodriguez   | USA TODAY Show Caption Hide Caption Coronavirus Chronicles: COVID survivors suffer weeks after virus clears COVID survivors’ main symptoms can linger for weeks or even months, causing pain, trouble breathing, nightmares and even organ failure. Jenny Berz was infected with the coronavirus in March after returning from a trip to Hawaii. The 50-year-old
0 Comments
Moncef Slaoui, a former GlaxoSmithKline executive, speaks with President Donald J. Trump during a vaccine development event in the Rose Garden at the White House on Friday, May 15, 2020 in Washington, DC. Jabin Botsford | The Washington Post | Getty Images The United States could immunize Americans “most susceptible” to Covid-19 by December if
0 Comments
President Donald Trump. | Alex Brandon/AP Photo President Donald Trump predicted Monday that a coronavirus vaccine would become available “within a matter of weeks,” again contradicting the assessments of his own administration’s top public health officials. “I’m getting it very soon, within a matter of weeks,” Trump told “Fox & Friends” in an interview, adding:
0 Comments